• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Locoregional Management After Neoadjuvant Chemotherapy.

作者信息

Morrow Monica, Khan Atif J

机构信息

Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.

Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.

出版信息

J Clin Oncol. 2020 Jul 10;38(20):2281-2289. doi: 10.1200/JCO.19.02576. Epub 2020 May 22.

DOI:10.1200/JCO.19.02576
PMID:32442069
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7343435/
Abstract
摘要

相似文献

1
Locoregional Management After Neoadjuvant Chemotherapy.新辅助化疗后的局部区域管理
J Clin Oncol. 2020 Jul 10;38(20):2281-2289. doi: 10.1200/JCO.19.02576. Epub 2020 May 22.
2
Imaging in Locoregional Management of Breast Cancer.乳腺癌局部区域治疗中的影像学检查
J Clin Oncol. 2020 Jul 10;38(20):2351-2361. doi: 10.1200/JCO.19.03257. Epub 2020 May 22.
3
Adjuvant chemotherapy might show benefit in luminal B breast cancer patients with isolated locoregional recurrence.辅助化疗可能对孤立性局部区域复发的腔面B型乳腺癌患者有益。
J BUON. 2019 Jan-Feb;24(1):405-406.
4
Efficacy of Neoadjuvant Endocrine Therapy Versus Neoadjuvant Chemotherapy in luminal A or luminal B breast cancer patients: Does it matter?新辅助内分泌治疗与新辅助化疗对腔面A型或腔面B型乳腺癌患者的疗效：这重要吗？
J BUON. 2019 Nov-Dec;24(6):2581.
5
[Neoadjuvant chemotherapy of breast cancer].[乳腺癌的新辅助化疗]
Zhonghua Yi Xue Za Zhi. 2007 Mar 13;87(10):653-6.
6
Neoadjuvant chemotherapy for breast cancer-background for the indication of locoregional treatment.乳腺癌新辅助化疗-局部区域治疗适应证的背景。
Strahlenther Onkol. 2018 Sep;194(9):797-805. doi: 10.1007/s00066-018-1329-8. Epub 2018 Jul 4.
7
[Effect of neoadjuvant chemotherapy on the overall treatment strategy in operable breast cancer].新辅助化疗对可手术乳腺癌整体治疗策略的影响
Zhonghua Zhong Liu Za Zhi. 2017 Dec 23;39(12):952-957. doi: 10.3760/cma.j.issn.0253-3766.2017.12.014.
8
Flipping a Coin? Predicting Nodal Status After Neoadjuvant Chemotherapy.抛硬币？预测新辅助化疗后的淋巴结状态。
Ann Surg Oncol. 2019 Dec;26(13):4168-4170. doi: 10.1245/s10434-019-07868-w. Epub 2019 Sep 25.
9
Systemic Therapies for Nonmetastatic Breast Cancer: The Role of Neoadjuvant and Adjuvant Chemotherapy and the Use of Endocrine Therapy.非转移性乳腺癌的全身治疗：新辅助化疗和辅助化疗的作用以及内分泌治疗的应用
Clin Obstet Gynecol. 2016 Dec;59(4):756-771. doi: 10.1097/GRF.0000000000000237.
10
Breast MRI for management of patients with locally advanced breast cancer who are being referred for neoadjuvant chemotherapy.乳腺磁共振成像用于指导接受新辅助化疗的局部晚期乳腺癌患者的治疗。
Technol Eval Cent Assess Program Exec Summ. 2004 Sep;19(7):1-4.

引用本文的文献

1
Omitting Regional Nodal Irradiation after Response to Neoadjuvant Chemotherapy.新辅助化疗有效后省略区域淋巴结照射
N Engl J Med. 2025 Jun 5;392(21):2113-2124. doi: 10.1056/NEJMoa2414859.
2
Factors associated with locoregional recurrence after neoadjuvant chemotherapy for breast cancer in a safety-net medical center.在一家安全网医疗中心，与乳腺癌新辅助化疗后局部区域复发相关的因素。
Breast Cancer Res Treat. 2025 Jun;211(2):517-526. doi: 10.1007/s10549-025-07668-9. Epub 2025 Mar 4.
3
Design Paper: A Prospective, Multicenter, Single-arm, Phase II Trial of Tailored Axillary Surgery in Patients with Clinically Node-positive Breast Cancer in the Upfront Surgery Setting.设计论文：在初始手术环境下，针对临床腋窝淋巴结阳性乳腺癌患者进行个体化腋窝手术的一项前瞻性、多中心、单臂、II期试验。
JMA J. 2025 Jan 15;8(1):264-269. doi: 10.31662/jmaj.2024-0187. Epub 2024 Dec 20.
4
Predicting nodal response to neoadjuvant treatment in breast cancer with core biopsy biomarkers of tumor microenvironment using data mining.利用数据挖掘技术，通过肿瘤微环境的核心活检生物标志物预测乳腺癌新辅助治疗的淋巴结反应。
Breast Cancer Res Treat. 2025 Feb;210(1):87-94. doi: 10.1007/s10549-024-07539-9. Epub 2024 Nov 4.
5
Shifting the Paradigm: The Transformative Role of Neoadjuvant Therapy in Early Breast Cancer.转变模式：新辅助治疗在早期乳腺癌中的变革性作用。
Cancers (Basel). 2024 Sep 23;16(18):3236. doi: 10.3390/cancers16183236.
6
Is neoadjuvant chemotherapy necessary for T2N0-1M0 hormone receptor-positive/HER2-negative breast cancer patients undergoing breast-conserving surgery?对于接受保乳手术的 T2N0-1M0 激素受体阳性/HER2 阴性乳腺癌患者，新辅助化疗是否必要？
J Cancer Res Clin Oncol. 2024 May 30;150(5):285. doi: 10.1007/s00432-024-05810-6.
7
Impact of residual microcalcifcations on prognosis after neoadjuvant chemotherapy in breast cancer patients.新辅助化疗后乳腺癌患者残余微钙化对预后的影响。
BMC Womens Health. 2024 Mar 20;24(1):187. doi: 10.1186/s12905-024-02973-9.
8
Axillary ultrasound for predicting response to neoadjuvant treatment in breast cancer patients-a single institution experience.腋窝超声预测乳腺癌患者新辅助治疗反应的单中心经验。
World J Surg Oncol. 2023 Sep 16;21(1):292. doi: 10.1186/s12957-023-03174-8.
9
An Innovative Scoring System to Select the Optimal Surgery in Breast Cancer after Neoadjuvant Chemotherapy.一种用于选择新辅助化疗后乳腺癌最佳手术方式的创新评分系统。
J Pers Med. 2023 Aug 21;13(8):1280. doi: 10.3390/jpm13081280.
10
A Survey of Practice Patterns for Clinical Nodal Staging Prior to Neoadjuvant Chemotherapy in Breast Cancer.新辅助化疗前乳腺癌临床淋巴结分期实践模式调查。
Oncologist. 2023 Dec 11;28(12):e1142-e1151. doi: 10.1093/oncolo/oyad156.

本文引用的文献

1
Surgical Management of the Axilla in Clinically Node-Positive Patients Receiving Neoadjuvant Chemotherapy: A National Cancer Database Analysis.接受新辅助化疗的临床淋巴结阳性患者腋窝的外科处理：国家癌症数据库分析。
Ann Surg Oncol. 2019 Oct;26(11):3517-3525. doi: 10.1245/s10434-019-07583-6. Epub 2019 Jul 24.
2
Prognostic Significance of Residual Axillary Nodal Micrometastases and Isolated Tumor Cells After Neoadjuvant Chemotherapy for Breast Cancer.新辅助化疗后乳腺癌腋窝残留淋巴结微转移和孤立肿瘤细胞的预后意义。
Ann Surg Oncol. 2019 Oct;26(11):3502-3509. doi: 10.1245/s10434-019-07517-2. Epub 2019 Jun 21.
3
Impact of Radiation on Locoregional Control in Women with Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy and Axillary Lymph Node Dissection: Results from ACOSOG Z1071 Clinical Trial.接受新辅助化疗和腋窝淋巴结清扫的淋巴结阳性乳腺癌女性中，放疗对局部区域控制的影响：来自 ACOSOG Z1071 临床试验的结果。
Int J Radiat Oncol Biol Phys. 2019 Sep 1;105(1):174-182. doi: 10.1016/j.ijrobp.2019.04.038. Epub 2019 May 11.
4
Development and Validation of a Nomogram to Predict Lymphedema After Axillary Surgery and Radiation Therapy in Women With Breast Cancer From the NCIC CTG MA.20 Randomized Trial.基于 NCIC CTG MA.20 随机试验的女性乳腺癌腋窝手术后和放疗后淋巴水肿预测列线图的开发和验证。
Int J Radiat Oncol Biol Phys. 2019 Sep 1;105(1):165-173. doi: 10.1016/j.ijrobp.2019.05.002. Epub 2019 May 11.
5
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer.曲妥珠单抗-美坦新偶联物用于治疗残留浸润性 HER2 阳性乳腺癌。
N Engl J Med. 2019 Feb 14;380(7):617-628. doi: 10.1056/NEJMoa1814017. Epub 2018 Dec 5.
6
Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study.新辅助化疗后前哨淋巴结活检而不进行腋窝淋巴结清扫对选定患者准确且安全：GANEA 2 研究。
Breast Cancer Res Treat. 2019 Jan;173(2):343-352. doi: 10.1007/s10549-018-5004-7. Epub 2018 Oct 20.
7
Meta-analysis of sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with initial biopsy-proven node-positive breast cancer.新辅助化疗后初始活检阳性乳腺癌患者前哨淋巴结活检的荟萃分析。
Br J Surg. 2018 Nov;105(12):1541-1552. doi: 10.1002/bjs.10986.
8
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial.腋窝清扫与未清扫对乳腺癌伴前哨淋巴结微转移患者的影响（IBCSG 23-01）：一项随机、对照、3 期临床试验的 10 年随访结果。
Lancet Oncol. 2018 Oct;19(10):1385-1393. doi: 10.1016/S1470-2045(18)30380-2. Epub 2018 Sep 5.
9
Margins in Breast-Conserving Surgery After Neoadjuvant Therapy.新辅助治疗后保乳手术的边缘。
Ann Surg Oncol. 2018 Nov;25(12):3541-3547. doi: 10.1245/s10434-018-6702-4. Epub 2018 Aug 20.
10
Long-Term Impact of Regional Nodal Irradiation in Patients With Node-Positive Breast Cancer Treated With Neoadjuvant Systemic Therapy.局部区域淋巴结照射对新辅助化疗治疗阳性淋巴结乳腺癌患者的长期影响。
Int J Radiat Oncol Biol Phys. 2018 Nov 1;102(3):568-577. doi: 10.1016/j.ijrobp.2018.06.016. Epub 2018 Jun 19.